Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy

Journal of Nephrology

Volumn 20, Issue 6, 2007, Pages 689-695

  Gastaldi, Daniela ^a   Paradisi, Luciana ^a   Baiocchi, Claudio ^a   Medana, Claudio ^a   Lo Duca, Giuseppina ^a   Sena, Luigi M ^a   Roccatello, Dario ^a,b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b S GIOVANNI BOSCO HOSPITAL   (Italy)

^c Ospedale Evangelico Valdese di Torino   (Italy)

Author keywords

Electrospray; IgA nephropathy; Liquid chromatography mass spectrometry; O glycans

Indexed keywords

GLYCAN DERIVATIVE; IMMUNOGLOBULIN A1; JACALIN; LECTIN; N ACETYLGALACTOSAMINE; TRYPSIN;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; ION TRAP MASS SPECTROMETRY; LECTIN BINDING SITE; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DETERMINATION;

ADULT; AGED; AMINO ACID MOTIFS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; MALE; MASS SPECTROMETRY; MIDDLE AGED; POLYSACCHARIDES;

EID: 39449110140     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Saulsbury FT. Heavy and light chain composition of serum IgA and IgA rheumatoid factor in Henoch-Schönlein purpura. Arthritis Rheum 1992; 35: 1370-80.
2. Julian BA, Tomana M, Novak J, Mestecky J. Progress in the pathogenesis of IgA nephropathy. Adv Nephrol 1999; 29: 53-72.
3. Field MC, Dwek RA, Edge CJ, Rademacher TW. O-linked oligosaccharides from human serum immunoglobulin A1. Biochem Soc Trans 1989; 17: 1034-5.
4. Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 1999; 10:1763-71.
5. Mellis SJ, Baenziger JU. Structures of the O-glycosidically linked oligosaccharides of human IgD. J Biol Chem 1983; 258: 11557-63.
6. Andre PM, Pogamp PL, Chevet D. Impairment of jacalin binding to serum IgA in IgA nephropathy. J Clin Lab Anal 1990; 4: 115-9.
7. Tomino Y, Ohmuro H, Takahashi Y, Suzuki Y, Saka S, Tashiro K, Shirato I, Koide H. Binding capacity of serum IgA to jacalin in patients with IgA nephropathy using jacalin-coated microplates. Nephron 1995; 70: 329-33.
8. Hashim OH, Shuib AS, Chua CT. The interaction of selective plant lectins with neuraminidase-treated and untreated IgA1 from the sera of IgA nephropathy patients. Immunol Invest 2001; 30: 21-31.
9. Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 2000; 95: 1253-7.
10. Laemmli UK. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 1970; 277: 680-5.
11. Hames BD. An introduction to polycrylamide gel electrophoresis. In Hames BD, Rickwood D Eds. Gel electrophoresis of proteins: a pratical approach. Oxford (UK): IRL Press 1981; 1-91.
12. Odani H, Hiki Y, Takahashi M, Nishimoto A, Yasuda Y, Iwase H, Shinzato T, Maeda K. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem Biophys Res Commun 2000; 271: 268-74.
13. Allen AC, Harper SJ, Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995; 100: 470-4.
14. Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J. Galactose-deficient IgA1 in sera of IgA nephropathy patiens is present in complexes with IgG. Kidney Int 1997; 52: 509-16.
15. Allen AC, Willis FR, Beattie TJ, Feehally J. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patiens with clinical nephritis. Nephrol Dial Transplant 1998, 13: 930-4.
16. Saulsbury FT. Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura. J Rheumatol 1997; 24: 2246-9.
17. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999; 104: 73-81.
18. Roccatello D, Picciotto G, Coppo R, Piccoli G, Molino A, Cacace G, Amore A, Amoroso A, Quattrocchio G, Sena LM. Clearence of polymeric IgA aggregates in humans. Am J Kidney Dis 1989; 14: 354-60.
19. Roccatello D, Picciotto G, Popolo R, Coppo R, Quattrocchio G, Cacace G, Molino A, Amoroso A, Baccega M, Isidoro C, Cardosi R, Sena LM, Piccoli G. Kinetics and fate of IgA-IgG aggregates as a model of naturally occurring immune complexes in IgA nephropathy. Lab Invest 1992; 66: 86-95.
20. Roccatello D, Picciotto G, Torchio MM, Ropolo R, Ferro M, Franceschini R, Quattrocchio G, Cacace G, Coppo R, Sena LM, De Filippi PG, Piccoli G. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients: the role of asialoglycoprotein receptors. Lab Invest 1993; 69: 714-23.
21. Carayannopoulos L, Hexham JM, Capra JD. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Cα2 and Cα3 in human IgA1. J Exp Med 1996; 183: 1579-86.
22. Grossetete B, Launay P, Lehuen A, Jungers P, Bach JF, Monteiro RC. Down regulation of Fcα receptors on blood cells of IgA nephropathy patiens: evidence for a negative regulatory role of serum IgA. Kidney Int 1998; 53: 1321-35.
23. Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, Julian Ba, Konecny K, Mestecky J. IgA-containing immune complexes in the urine of IgA nephropathy patiens. Nephrol Dial Transplant 2006; 21: 2478-84.
24. Mestecky J, Hashim OH, Tomana M. Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1. Contrib Nephrol 1995; 111: 66-72.
25. Launay P, Grossetete B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, Patey-Mariaud De Serre N, Lehuen A, Monteiro RC. Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease): evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J Exp Med 2000; 191: 1999-2000.
26. Nikolova EB, Tomana M, Russell MW. All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone. Scand J Immunol 1994; 39: 275-80.